Kat Toups, M.D., DFAPA, IFMCP, is the Lead Co-Principal Investigator of the Evanthea and Four Winds Precision Medicine Dementia Reversal Trials and a board-certified neuropsychiatrist specializing in geriatric psychiatry and cognitive decline, with nearly four decades of clinical experience. 

 

She began her medical career practicing as a general physician in an underserved border community before completing specialty training in psychiatry and later earning subspecialty certification in geriatric psychiatry.

 

Dr. Toups has held academic and leadership appointments at the University of California, Davis, including Assistant Professor of Clinical Psychiatry, Chief of Inpatient Psychiatry at the VA, and Residency Training Site Director at David Grant Medical Center, Travis Air Force Base.

 

She has served as principal investigator on more than 100 clinical trials, including over 20 focused on mild cognitive impairment and Alzheimer’s disease, and founded and directed a clinical trials research center for 13 years.

 

Dr. Toups is a Functional Medicine psychiatrist, clinical researcher, and educator in the field of cognitive health. She has been an invited and keynote speaker at numerous national and international medical conferences on dementia and functional medicine psychiatry, and is also a frequent guest on podcasts and educational summits.

 

Her work focuses on personalized, systems-based approaches to brain health, addressing metabolic, infectious, inflammatory, immune, hormonal, vascular, toxic, and lifestyle contributors to cognitive decline. 

 

In collaboration with Dale Bredesen and colleagues, her research has explored the potential to improve—and in many cases reverse—early cognitive impairment using multimodal precision medicine approaches.

 

Dr. Toups has authored peer-reviewed publications cited more than 130 times, including studies published in the Journal of Alzheimer’s Disease, and has contributed chapters to several medical textbooks. She also serves on the board of the Alzheimer’s Survivors Foundation and is actively involved in advancing awareness of personalized approaches to brain health.

 

She is committed to helping patients and families move beyond a diagnosis-focused model toward identifying and addressing the potentially modifiable contributors to cognitive decline as well as psychiatric illness.